Carrying excess weight around the waist can be a predictor of chronic disease, and men may be at risk more than women ...

After the massive success of GLP-1 agonists to manage obesity, researchers are looking at new molecules that might hold ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

GLP-1 drugs are remarkably effective at addressing obesity, cardiovascular, and metabolic conditions, but investigators ...

Indulging dogs with rich, high-calorie food and human-like lifestyles leads to diabetes, joint issues, and heart problems ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

The study highlighted interventions to reduce heart failure risk — most notably hypertension control and weight loss.

Childhood obesity has emerged as a significant public health concern, with the World Health Organization labeling it an ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

Death rates linked to obesity-related heart disease nearly tripled in our country over a two-decade span. The rate for men ...

Blood vessels supply oxygen and nutrients to our body's tissues and organs, including the heart, brain, and kidneys, and ...